The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,014,596 in first-year total cost, median $206,501.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section [AMSC]13
- Special Emphasis Panel[ZAR1 HL (M1)]1
Most frequent institutions
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH2
- CASE WESTERN RESERVE UNIVERSITY1
- DUKE UNIVERSITY1
- HIGH POINT UNIVERSITY1
- HOSPITAL FOR SPECIAL SURGERY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | A Pilot Study of the Effect of Intravenous Gentamicin on the Restoration of Full-Length Type VII Collagen in RDEB Patients Carrying Nonsense Mutations1R21AR071716-01A1 | CHEN, MEIWOODLEY, DAVID T. | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $290,400 | AMSC |
| 2018 | REduCing Immunogenicity to PegloticasE (RECIPE)1R21AR071684-01A1 | SAAG, KENNETH G | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $260,406 | AMSC |
| 2017 | Dimethyl Fumarate In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension1R21AR069285-01A1 | FARBER, HARRISON WLAFYATIS, ROBERT A. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $236,840 | AMSC |
| 2017 | Reduction of Risk Factors for ACL Re-injuries using an Innovative Biofeedback Approach1R21AR069865-01A1 | QUEEN, ROBIN M | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $183,392 | AMSC |
| 2017 | A Novel Physical Therapy Administered Physical Activity Intervention After TKR1R21AR071079-01A1 | WHITE, DANIEL K | UNIVERSITY OF DELAWARE, DE | $168,288 | AMSC |
| 2016 | TNF-alpha Blockade with Certolizumab to Prevent Pregnancy Complications in High-Risk Patients with APS1R21AR069189-01A1 | BRANCH, D.WARESALMON, JANE E | HOSPITAL FOR SPECIAL SURGERY, NY | $251,908 | ZAR1 |
| 2016 | Respiratory Muscle Training in Late-Onset Pompe Disease1R21AR069880-01 | JONES, HARRISON N. | DUKE UNIVERSITY, NC | $224,494 | AMSC |
| 2016 | Real-time Optimized Biofeedback Utilizing Sport Techniques (ROBUST)1R21AR069873-01 | FORD, KEVIN RAY | HIGH POINT UNIVERSITY, NC | $208,567 | AMSC |
| 2016 | Prevention of Skeletal Muscle Adaptations to Traumatic Knee Injury and Surgery1R21AR069199-01A1 | BEYNNON, BRUCETOTH, MICHAEL J | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $204,435 | AMSC |
| 2016 | Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?1R21AR069174-01A1 | LIANG, KIMBERLY PMORELAND, LARRY W | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $187,079 | AMSC |
| 2016 | Consolidating Skeletal Benefits after Short-Term Combination Osteoporosis Therapy; The DATA-EX Study1R21AR069871-01 | LEDER, BENJAMIN Z | MASSACHUSETTS GENERAL HOSPITAL, MA | $185,601 | AMSC |
| 2016 | Cell-based Therapy in RA: Proof of Concept1R21AR069226-01A1 | LAZARUS, HILLARD MSINGER, NORA | CASE WESTERN RESERVE UNIVERSITY, OH | $182,311 | AMSC |
| 2015 | First-in-Human rAAVrh74.MCK.GALGT2 DMD Clinical Trial1R21AR068040-01 | FLANIGAN, KEVIN M | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $263,120 | AMSC |
| 2015 | Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project1R21AR068615-01 | ECONS, MICHAEL J | INDIANA UNIVERSITY INDIANAPOLIS, IN | $167,755 | AMSC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.